MitraClip REPAIR MR Study
Diseases of the Cardiovascular System
What is the purpose of this trial?
The objective of this randomized controlled trial (RCT) is to compare the clinical outcome of MitraClip™ device versus surgical repair in patients with severe primary MR who are at moderate surgical risk and whose mitral valve has been determined to be suitable for correction by MV repair surgery by the cardiac surgeon on the local site heart team.
- Ages18 years and older
- Trial withAbbott Cardiovascular Systems, Inc.
- Start Date11/01/2021
- End Date02/28/2024
- Last Updated11/11/2022
- Study HIC#2000031013